HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel RYR1 variant in an infant with a unique fetal presentation of central core disease.

Abstract
Ryanodine receptor type 1-related disorder (RYR1-RD) is the most common subgroup of congenital myopathies with a wide phenotypic spectrum ranging from mild hypotonia to lethal fetal akinesia. Genetic testing for myopathies is imperative as the diagnosis informs counseling regarding prognosis and recurrence risk, treatment options, monitoring, and clinical management. However, diagnostic challenges exist as current options are limited to clinical suspicion prompting testing including: single gene sequencing or familial variant testing, multi-gene panels, exome, genome sequencing, and invasive testing including muscle biopsy. The timing of diagnosis is of great importance due to the association of RYR1-RD with malignant hyperthermia (MH). MH is a hypermetabolic crisis that occurs secondary to excessive calcium release in muscles, leading to systemic effects that can progress to shock and death if unrecognized. Given the association of MH with pathogenic variants in RYR1, a diagnosis of RYR1-RD necessitates an awareness of medical team to avoid potentially triggering agents. We describe a case of a unique fetal presentation with bilateral diaphragmatic eventrations who had respiratory failure, dysmorphic facial features, and profound global hypotonia in the neonatal period. The diagnosis was made at several months of age, had direct implications on her clinical care related to anticipated need to long-term ventilator support, and ultimately death secondary an arrhythmia as a result of suspected MH. Our report reinforces the importance of having high suspicion for a genetic syndrome and pursuing early, rapid exome or genome sequencing as first line testing in critically ill neonatal intensive care unit patients and further evaluating the pathogenicity of a variant of uncertain significance in the setting of a myopathic phenotype.
AuthorsElizabeth K Baker, Faris N Al Gharaibeh, Kevin Bove, Maria A Calvo-Garcia, Amelle Shillington, Katherine VandenHeuvel, DonnaMaria E Cortezzo
JournalAmerican journal of medical genetics. Part A (Am J Med Genet A) Vol. 191 Issue 6 Pg. 1646-1651 (06 2023) ISSN: 1552-4833 [Electronic] United States
PMID36965156 (Publication Type: Case Reports)
Copyright© 2023 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.
Chemical References
  • Ryanodine Receptor Calcium Release Channel
Topics
  • Female
  • Humans
  • Pregnancy
  • Myopathy, Central Core (diagnosis, genetics)
  • Ryanodine Receptor Calcium Release Channel (genetics)
  • Muscle Hypotonia
  • Chromosome Mapping
  • Labor Presentation
  • Malignant Hyperthermia (diagnosis, genetics)
  • Mutation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: